DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge

Intervirology. 2000;43(4-6):288-93. doi: 10.1159/000053996.

Abstract

The present study was undertaken to examine the immunogenicity of a single plasmid DNA representing the reverse transcriptase (RT) of HIV-1. Plasmids containing the enzymatically active RT as well as a mutated nonenzymatically active RT with nucleotide (nt)-binding motifs of YMDD and YMLL, respectively, were used to immunize mice. Both constructs induced similar good antibody and T cell responses, with a tendency towards antibody directed to peptides representing the active and mutated sites. Immunized mice were challenged with a murine pseudotype HIV-1/MuLV infected spleen cells. Seven out of 10 mice immunized with RT had no recoverable HIV-1, while 10 individuals immunized with the RT mutant and all the 18 controls had high levels of recoverable HIV-1. This indicates that mutation of RT reduces the desired immunogenicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / genetics
  • AIDS Vaccines / immunology*
  • Amino Acid Sequence
  • Animals
  • Cells, Cultured
  • Disease Models, Animal
  • HIV Infections / prevention & control*
  • HIV Reverse Transcriptase / genetics*
  • HIV Reverse Transcriptase / immunology*
  • HIV Reverse Transcriptase / metabolism
  • HIV-1 / immunology
  • Humans
  • Immunization
  • Leukocytes, Mononuclear
  • Mice
  • Mice, Inbred C57BL
  • Molecular Sequence Data
  • Mutation
  • Peptides / chemical synthesis
  • Vaccines, DNA / administration & dosage
  • Vaccines, DNA / immunology*

Substances

  • AIDS Vaccines
  • Peptides
  • Vaccines, DNA
  • HIV Reverse Transcriptase